Cannabis Regulation
Cannabis Regulation · page 2
- Cultivation
Future-Ready: Why Pure Is Building the Cannabis Company Traditional Industry Will Want to Buy Into
Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its plans for cannabis reform.
- Industry Trends
Bundesrat Backs Tighter Cannabis Prescribing Rules, Rejects Mail-Order Penalties
Germany’s Bundesrat voted on November 21 to support key restrictions on medical cannabis prescribing and distribution, while rejecting proposals to ban prescriptions being sent via mail, a mixed outcome that offers both relief and concern for an industry bracing for regulatory tightening.
- Clinical Research
How to Read a Cannabis Research Paper
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal.
- US & Canada
How New York’s Next Mayor Will Shape the Future of Cannabis in the State
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the state’s vast but unsettled cannabis market has become a key battleground for the three hopefuls.
- US & Canada
Countdown to Business of Cannabis: New York 2025, Celebrating Our Pioneering Sponsors
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300 leaders from across the cannabis ecosystem for a day of strategic dialogue, networking, and market insight.
- Clinical Research
Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our understanding of its use cases, and more importantly, fill the long-maligned gap in clinical evidence.
- International Regulation
Drug War 2.0 Puts International Cannabis Reform at Risk
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy, a combination that threatens to reshape the outlook for cannabis reform and regulation This morning, news broke that the US military had carried out another series of airstrikes on alleged drug traffickers in the Eastern…
- Press releases
Why You Should Attend Business of Cannabis: New York
Industry leaders, regulators and investors meet at Business of Cannabis New York to discuss funding, regulation and sustainable market growth.
- Medical Cannabis
California Medical Cannabis Home Delivery Bill Vetoed by Governor Newsom
California Governor Gavin Newsom has vetoed legislation that would have allowed certain cannabis microbusinesses to ship medical products directly to patients using common carriers such as FedEx and UPS, citing concerns that the proposed system would be ‘burdensome and overly complex to administer’.
- Uncategorized
What’s On the Agenda for Business of Cannabis: New York 2025?
Industry leaders, regulators and investors meet at Business of Cannabis New York to discuss funding, regulation and sustainable market growth.
- UK & Europe
Cannabis Researchers Call for Implementation of Second Pillar of the KCanG
When Germany introduced the Recreational Cannabis Act (KCanG), it not only legalised home cultivation and consumption for adults but also laid the groundwork for scientifically monitored pilot projects allowing the legal sale of cannabis at authorised distribution points.
- Pharmaceutical
Europe’s First Ever ‘Whole Plant’ Cannabis Medicine Could be Available by 2026 in Major Step Forward for Non-Opioid Pain Treatment
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval.
